TCTR20201025001Not yet recruitingPhase 1
Pharmacokinetic, safety, and efficacy of dolutegravir dispersible tablet in young children living with HIV.
Faculty of Medicine, Chulalongkorn University0 sites24 target enrollmentStarted: October 25, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 Months to 6 Years (—)
- Sex
- All
Inclusion Criteria
- •1. children with HIV infection weight 6-<20 kg
- •2. never receiving integrase inhibitor for treat their HIV
Exclusion Criteria
- •1. active HIV disease or active opportunistic infection
- •2. liver impairment (ALT >100 IU/mL)
- •3. Renal impairment (GFR <60 mL/min)
- •4. concurrently treat with drug which have drug interaction to DTG
Investigators
Similar Trials
Completed
Not Applicable
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerProstate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20
Active, not recruiting
Phase 1
Clinical trial to evaluate the efficacy, safety and pharmacokinetics profile of nebulized Aztreonam Lysine (AZLI) for prevention of Gram negative pneumonia in heavily colonized mechanically ventilated patientsGram negative pneumonia in heavily colonized mechanically ventilated patientsMedDRA version: 20.0Level: LLTClassification code 10035725Term: Pneumonia NOSSystem Organ Class: 100000004862EUCTR2018-003865-32-ESAlejandro Rodriguez Oviedo - Critical Care Department – Hospital Universitario de Tarragona Joan XXIII20
Active, not recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and safety of a new Leuprolide acetate 22.5 mg depot formulation, when given as palliative treatment to prostate cancer patientsMedDRA version: 8.1Level: LLTClassification code 10007113Term: Cancer of prostateProstate cancerEUCTR2006-005964-24-GBItalfarmaco S.p.A.20
Active, not recruiting
Not Applicable
Pharmacokinetics, pharmacodynamics and safety of intra-articular multiple doses of 500 mcg icatibant in an uncontrolled 13-week multi-center study in patients with symptomatic knee osteoarthritis - TRICAPEKAEUCTR2006-000763-29-LTSanofi-Aventis Deutschland GmbH12
Active, not recruiting
Not Applicable
Pharmacodynamic and clinical evaluation of dose and taste-optimised low volume PEG-based bowel cleansing solutions using the split-dosing intake regimen in healthy subjects and in subjects undergoing screening colonoscopyBowel cleansing prior to colonoscopyMedDRA version: 14.1Level: PTClassification code 10066943Term: Bowel preparationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-003052-37-DEorgine Ltd